| Combinatorial strategies for the induction of immunogenic cell death L Bezu, LC Gomes-da-Silva, H Dewitte, K Breckpot, J Fucikova, R Spisek, ... Frontiers in immunology 6, 187, 2015 | 460 | 2015 |
| Crizotinib-induced immunogenic cell death in non-small cell lung cancer P Liu, L Zhao, J Pol, S Levesque, A Petrazzuolo, C Pfirschke, C Engblom, ... Nature communications 10 (1), 1486, 2019 | 266 | 2019 |
| eIF2α phosphorylation is pathognomonic for immunogenic cell death L Bezu, A Sauvat, J Humeau, LC Gomes-da-Silva, K Iribarren, S Forveille, ... Cell Death & Differentiation 25 (8), 1375-1393, 2018 | 224 | 2018 |
| Trial watch: peptide-based vaccines in anticancer therapy L Bezu, O Kepp, G Cerrato, J Pol, J Fucikova, R Spisek, L Zitvogel, ... Oncoimmunology 7 (12), e1511506, 2018 | 175 | 2018 |
| Prognostic and predictive value of DAMPs and DAMP-associated processes in cancer J Fucikova, I Moserova, L Urbanova, L Bezu, O Kepp, I Cremer, C Salek, ... Frontiers in immunology 6, 402, 2015 | 170 | 2015 |
| ATP and cancer immunosurveillance O Kepp, L Bezu, T Yamazaki, F Di Virgilio, MJ Smyth, G Kroemer, ... The EMBO journal 40 (13), e108130, 2021 | 161 | 2021 |
| The oncolytic peptide LTX-315 triggers immunogenic cell death H Zhou, S Forveille, A Sauvat, T Yamazaki, L Senovilla, Y Ma, P Liu, ... Cell death & disease 7 (3), e2134-e2134, 2016 | 124 | 2016 |
| Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus LC Gomes‐da‐Silva, L Zhao, L Bezu, H Zhou, A Sauvat, P Liu, S Durand, ... The EMBO journal 37 (13), e98354, 2018 | 113 | 2018 |
| Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress J Humeau, A Sauvat, G Cerrato, W Xie, F Loos, F Iannantuoni, L Bezu, ... EMBO molecular medicine 12 (5), e11622, 2020 | 85 | 2020 |
| Trial watch: immune checkpoint blockers for cancer therapy C Vanpouille-Box, C Lhuillier, L Bezu, F Aranda, T Yamazaki, O Kepp, ... Oncoimmunology 6 (11), e1373237, 2017 | 80 | 2017 |
| eIF2α phosphorylation: A hallmark of immunogenic cell death L Bezu, A Sauvat, J Humeau, M Leduc, O Kepp, G Kroemer Oncoimmunology 7 (6), e1431089, 2018 | 61 | 2018 |
| Identification of pharmacological agents that induce HMGB1 release P Liu, L Zhao, F Loos, K Iribarren, S Lachkar, H Zhou, LC Gomes-da-Silva, ... Scientific reports 7 (1), 14915, 2017 | 52 | 2017 |
| The oncolytic peptide LTX-315 triggers necrotic cell death S Forveille, H Zhou, A Sauvat, L Bezu, K Müller, P Liu, L Zitvogel, ... Cell Cycle 14 (21), 3506-3512, 2015 | 48 | 2015 |
| Trans-fats inhibit autophagy induced by saturated fatty acids A Sauvat, G Chen, K Müller, M Tong, F Aprahamian, S Durand, G Cerrato, ... EBioMedicine 30, 261-272, 2018 | 41 | 2018 |
| The oncolytic compound LTX-401 targets the Golgi apparatus H Zhou, A Sauvat, LC Gomes-da-Silva, S Durand, S Forveille, K Iribarren, ... Cell Death & Differentiation 23 (12), 2031-2041, 2016 | 33 | 2016 |
| EIF2α phosphorylation: a hallmark of both autophagy and immunogenic cell death J Humeau, L Bezu, O Kepp, G Kroemer Molecular & Cellular Oncology 7 (5), 1776570, 2020 | 30 | 2020 |
| Identification of pharmacological inhibitors of conventional protein secretion L Zhao, P Liu, G Boncompain, F Loos, S Lachkar, L Bezu, G Chen, ... Scientific reports 8 (1), 1-11, 2018 | 27 | 2018 |
| Endoplasmic reticulum stress in the cellular release of damage-associated molecular patterns AW Chuang, O Kepp, G Kroemer, L Bezu International Review of Cell and Molecular Biology 350, 1-28, 2020 | 25 | 2020 |
| Immunological effects of epigenetic modifiers L Bezu, A Wu Chuang, P Liu, G Kroemer, O Kepp Cancers 11 (12), 1911, 2019 | 23 | 2019 |
| Autophagy-mediated metabolic effects of aspirin F Castoldi, J Humeau, I Martins, S Lachkar, D Loew, F Dingli, S Durand, ... Cell Death Discovery 6 (1), 129, 2020 | 22 | 2020 |